Why subscribe?

APTM is a news product from Analytic Powertools a premiere suite of products for pharmaceutical valuations and portfolio analysis.

Our goals are to help you know what interesting drug assets are currently in development AND to help you understand pharmaceutical valuations more clearly.

APTM will comb through hundreds of drugs currently in clinical trials and provide valuations and analysis.

As leaders in the pharmaceutical and biotech industry our hope is you’ll gain deeper insights on how to build and understand valuations as well as how to prioritize which assets to put more resources into.

Why do we exist?

R&D is a very expensive venture and most drugs will fail in trials. So building valuations and understanding which assets to allocate resources to is a critical function of any company who wants to make drugs. W

This publication is a core part of the Analytic Powertools mission; to provide not only a premiere suite of products for pharmaceutical valuations and portfolio analysis, but also to share the most valuable insights and valuations produced by Analytic Powertools.

Stay up-to-date

Never miss an update on our articles. Every new post is sent directly to your email inbox. For a spam-free, ad-free reading experience, plus audio and community features, get the Substack app.